Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Tampons

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44339   clinical trials with a EudraCT protocol, of which   7369   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    11 result(s) found for: Tampons. Displaying page 1 of 1.
    EudraCT Number: 2007-001389-34 Sponsor Protocol Number: PSD508-DYS-001 Start Date*: 2007-10-30
    Sponsor Name:Plethora Solutions Limited
    Full Title: A multi-centre, double-blind, placebo-controlled, multiple-dose crossover proof of concept study to compare the efficacy of mefenamic acid administered vaginally and orally in healthy menstruating ...
    Medical condition: Primary dysmenorrhoea requiring analgesia
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036689 Primary dysmenorrhoea LLT
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-004340-32 Sponsor Protocol Number: 308961 Start Date*: 2006-04-20
    Sponsor Name:Bayer Schering Pharma AG
    Full Title: A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, 7 Cycle Duration (196 Days), Phase 3 Study of Oral Estradiol Valerate/Dienogest Tablets for the Treatment of Dysfunction...
    Medical condition: Treatment of prolonged, excessive or frequent bleeding in women without organic pathology who desire oral contraception.
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (Completed) SE (Completed) DE (Completed) FI (Completed) HU (Completed) CZ (Completed)
    Trial results: View results
    EudraCT Number: 2012-003778-16 Sponsor Protocol Number: J005 Start Date*: 2013-04-24
    Sponsor Name:Guy's & St. Thomas' NHS Foundation Trust
    Full Title: A phase IV study to determine the oral and genital tract concentration of Maraviroc required for ex vivo protection from HIV-1 using Maraviroc 300mg stat
    Medical condition: HIV
    Disease: Version SOC Term Classification Code Term Level
    17.0 100000004862 10068341 HIV-1 infection LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2011-003147-22 Sponsor Protocol Number: GLBR-101-2011 Start Date*: 2011-12-02
    Sponsor Name:Glenmark Farmaceutica LTDA
    Full Title: A Multicenter, Open-Label, Comparator-Controlled, Parallel Group, Phase 3 Study to Assess the Efficacy and Safety of Clotrimazole/Clindamycin (200 mg/100 mg FDC) Ovules Compared with Metronidazole ...
    Medical condition: vaginitis
    Disease: Version SOC Term Classification Code Term Level
    14.0 10021881 - Infections and infestations 10046950 Vaginitis LLT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2009-016655-21 Sponsor Protocol Number: P-090756-01 Start Date*: 2010-04-30
    Sponsor Name:Ferrer Internacional, S.A
    Full Title: A Multi-Centre, Randomized, Placebo-controlled, Parallel-Group, Double-Blinded Study to Compare the Therapeutic Efficacy, Safety and Tolerability of 3 Single Vaginal Doses of Arasertaconazole Nitra...
    Medical condition: Vulvovaginal Candidiasis
    Disease: Version SOC Term Classification Code Term Level
    12.1 10047784 Vulvovaginal candidiasis PT
    Population Age: Adults Gender: Female
    Trial protocol: CZ (Completed) HU (Completed) FR (Completed) LT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2019-002350-22 Sponsor Protocol Number: LR-201 Start Date*: 2020-01-14
    Sponsor Name:Chemo Research S.L.
    Full Title: Multi-center, phase 2, open-label, randomized clinical trial to evaluate the inhibition of ovulation of 3 dosing strengths of levonorgestrel (LNG) vaginal delivery system (VDS), releasing during 28...
    Medical condition: Women´s healthcare (Contraception, inhibition of ovulation)
    Disease: Version SOC Term Classification Code Term Level
    20.0 10042613 - Surgical and medical procedures 10010808 Contraception PT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-011826-32 Sponsor Protocol Number: RFX-VAG/002/2008 Start Date*: Information not available in EudraCT
    Sponsor Name:Alfa Wassermann S.p.A.
    Full Title: A phase II, multicentre, double-blind, randomised, placebo-controlled study on efficacy and tolerability of Rifaximin vaginal tablets in the treatment of bacterial vaginosis
    Medical condition: Bacterial vaginosis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10004055 Bacterial vaginosis LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: DE (Completed) IT (Completed) BE (Completed)
    Trial results: View results
    EudraCT Number: 2021-004579-16 Sponsor Protocol Number: FU-04-21 Start Date*: 2022-01-18
    Sponsor Name:Adamed Pharma S.A.
    Full Title: A Phase II, Randomized, Parallel design, Open label, Dose ranging Study to evaluate the efficacy and safety of Furazidin vaginal tablets in women with bacterial vaginosis
    Medical condition: Bacterial Vaginosis (BV)
    Disease: Version SOC Term Classification Code Term Level
    20.1 10021881 - Infections and infestations 10004055 Bacterial vaginosis PT
    Population Age: Adults Gender: Female
    Trial protocol: PL (Completed) HU (Completed)
    Trial results: (No results available)
    EudraCT Number: 2016-000437-43 Sponsor Protocol Number: JF-007 Start Date*: 2017-04-28
    Sponsor Name:Guy's and St Thomas NHS Foundation Trust
    Full Title: The time to protection and adherence requirements of Raltegravir with or without lamivudine in protection from HIV infection
    Medical condition: HIV
    Disease: Version SOC Term Classification Code Term Level
    19.1 10021881 - Infections and infestations 10020161 HIV infection PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2016-000439-42 Sponsor Protocol Number: TAP Start Date*: 2019-12-31
    Sponsor Name:Guy's & St. Thomas' NHS Foundation Trust
    Full Title: The time to protection and adherence requirements of TRUVADA® and DESCOVY® required for protection from HIV-1 infection: bridging the data gaps
    Medical condition: Human Immunodeficiency Viruses
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021881 - Infections and infestations 10021881 Infections and infestations SOC
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2018-000915-26 Sponsor Protocol Number: 000295 Start Date*: 2019-05-10
    Sponsor Name:Ferring Pharmaceuticals A/S
    Full Title: A randomised, double-blind, placebo-controlled, proof-of-mechanism phase 2 trial investigating the effect of quinagolide extended-release vaginal ring on reduction of lesions assessed by high-resol...
    Medical condition: Deep infiltrating endometriosis, endometrioma and/or adenomyosis.
    Disease: Version SOC Term Classification Code Term Level
    21.0 100000004872 10014787 Endometriosis of uterus LLT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed) DK (Completed) IT (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Wed May 28 15:06:49 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA